NCT01730183View on ClinicalTrials.gov

To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Spinal Cord Injury
Interventions
OTHER

Bone marrow derived stem cells

Intrathecal administration of autologous bone marrow derived stem cells upto a cell dose of equal or greater than 10(8)BMMNCs.

Trial Locations (1)

248001

RECRUITING

Max Super speciality Hospital, Dehradun

Sponsors
All Listed Sponsors
lead

Max Institute of Neurosciences

INDUSTRY